We are boldly defining new benchmarks.
We are listening to what companies want from their drug development and device partners. We are listening to understand where the CRO industry has room to improve. A breakthrough environment with the agility to promote and respond to changes in trial design, development and delivery continues to be an imperative. We are taking action. We are forming Fortrea and along with it a new blueprint for excellence in customer service to equal our renowned scientific expertise.
Awakening unparalleled partnerships.
We believe in the power of partnership to fuel insights and unlock new possibilities. We offer our customers a tailored approach to clinical trial solutions through the use of three delivery models: full service, functional service providers or a hybrid approach. Our team of more than 19,000 professionals partners with emerging and large biopharma and medical device and diagnostic companies to support operations and drive healthcare innovation in nearly 100 countries.